PTEN negatively regulates miR-21 expression via the RNA-regulatory protein ribonuclease/angiogenin inhibitor 1 (RNH1), thereby preventing the downregulation of Spry2 by miR-21 in glioma cells (Kim et al., 2011; Kwak et al., 2011). Here, PTEN is linked to central nervous system cancer.